MiR-140a contributes to the pro-atherosclerotic phenotype of macrophages by downregulating interleukin-10

H-X Yang1, H-B Jiang, L Luo

  • 1YongZhou Vocational Technical College, Yongzhou City, Hunan Province, China. HengboJ@yeah.net.

Abstract

Insights

MicroRNA-140a promotes atherosclerosis by increasing inflammation in macrophages. This microRNA targets interleukin-10, reducing its anti-inflammatory effects and worsening the condition.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Immune cell dysfunction is a key driver of atherosclerosis (AS) progression.
  • Macrophages play a critical role in the inflammatory processes underlying AS.

Purpose of the Study:

  • To investigate the role of microRNA-140a (miR-140a) in regulating the function of macrophages associated with AS.
  • To determine if miR-140a influences the pro-inflammatory or anti-inflammatory responses of macrophages in the context of AS.

Main Methods:

  • Quantitative PCR was used to measure miR-140a expression in human monocytes.
  • Macrophages were treated with miR-140a mimics or inhibitors and stimulated with oxidized low-density lipoprotein (ox-LDL).
  • Cytokine production, macrophage phenotype, and STAT3 phosphorylation were analyzed.

Main Results:

  • miR-140a expression was found to be upregulated in monocytes from AS patients.
  • Overexpression of miR-140a enhanced the pro-inflammatory response of macrophages stimulated by ox-LDL.
  • miR-140a was identified as a direct target of interleukin-10 (IL-10), thereby suppressing IL-10-mediated anti-inflammatory actions.

Conclusions:

  • miR-140a acts as a pro-atherosclerotic microRNA.
  • It modulates the phenotypic switch of AS-associated macrophages, promoting a pro-inflammatory state.